|
Market Closed -
Oslo Bors
10:45:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 13.80 NOK | 0.00% |
|
-7.38% | -42.02% |
| 08-14 | Navamedic ASA, Q2 2026 Earnings Call, Aug 14, 2026 | |
| 08-14 | Navamedic Asa Provides Earnings Guidance for the Year 2026 | CI |
Company Valuation: Navamedic ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 555.8 | 601.2 | 636.8 | 453.9 | 570.8 | 330.9 | - | - |
| Change | - | 8.19% | 5.92% | -28.72% | 25.74% | -42.02% | - | - |
| Enterprise Value (EV) 1 | 542.1 | 597.9 | 745.4 | 453.9 | 702.3 | 450.4 | 427.8 | 382.8 |
| Change | - | 10.3% | 24.65% | -39.1% | 54.71% | -35.86% | -5.02% | -10.52% |
| P/E | 850x | 20.2x | 195x | - | -19.3x | -51.4x | 44.2x | 13.3x |
| PBR | - | 2.87x | 2.86x | 2.1x | - | 1.07x | 1.05x | 0.96x |
| PEG | - | 0x | -2.2x | - | - | 0.7x | -0x | 0x |
| Capitalization / Revenue | 2x | 1.57x | 1.24x | 0.85x | 1.01x | 0.58x | 0.55x | 0.51x |
| EV / Revenue | 1.95x | 1.56x | 1.46x | 0.85x | 1.24x | 0.79x | 0.71x | 0.59x |
| EV / EBITDA | 29.8x | 11.6x | 14.5x | 9.75x | 14.8x | 8.19x | 6.61x | 4.67x |
| EV / EBIT | 47.3x | 13.5x | 18.8x | 18.8x | 56.6x | 50.3x | 16.1x | 8.24x |
| EV / FCF | -267x | 38.1x | -7.28x | 12.8x | -4.36x | 10.2x | 8.93x | 6.72x |
| FCF Yield | -0.37% | 2.62% | -13.7% | 7.84% | -22.9% | 9.77% | 11.2% | 14.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.04 | 1.73 | 0.188 | - | -1.236 | -0.2682 | 0.3125 | 1.038 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 278.4 | 382.1 | 512 | 531.4 | 565.4 | 569.8 | 603.9 | 651.8 |
| EBITDA 1 | 18.2 | 51.69 | 51.57 | 46.55 | 47.61 | 54.99 | 64.74 | 82.04 |
| EBIT 1 | 11.46 | 44.44 | 39.64 | 24.13 | 12.4 | 8.951 | 26.64 | 46.44 |
| Net income 1 | 0.618 | 29.43 | 3.814 | 1.29 | -23.54 | -6.496 | 7.698 | 24.96 |
| Net Debt 1 | -13.64 | -3.304 | 108.5 | - | 131.5 | 119.5 | 96.9 | 51.9 |
| Reference price 2 | 34.00 | 34.90 | 36.70 | 25.70 | 23.80 | 13.80 | 13.80 | 13.80 |
| Nbr of stocks (in thousands) | 16,346 | 17,228 | 17,353 | 17,663 | 23,981 | 23,981 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/12/25 | 2/12/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -52.38x | 0.8x | 8.3x | - | 36.14M | |
| 33.02x | 11.99x | 24.3x | 0.6% | 1,034B | |
| 29.7x | - | - | 1.98% | 654B | |
| 33.18x | 7.69x | 15.99x | 2.64% | 459B | |
| 19.36x | 4.61x | 11.42x | 2.88% | 343B | |
| 22.91x | 5.89x | 14.6x | 2.71% | 307B | |
| 20.82x | 4.27x | 12.21x | 2.06% | 251B | |
| 27.71x | 7.15x | 12.7x | 2.3% | 237B | |
| 13.18x | 4.74x | 9.88x | 3.82% | 202B | |
| -45.81x | 6.6x | 25.78x | 2.2% | 186B | |
| Average | 10.17x | 5.97x | 15.02x | 2.35% | 367.16B | |
| Weighted average by Cap. | 24.07x | 8.04x | 17.80x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NAVA Stock
- Valuation Navamedic ASA
Select your edition
All financial news and data tailored to specific country editions
